Selective Availability of IL-2 Is a Major Determinant Controlling the Production of CD4+CD25+Foxp3+ T Regulatory Cells. 2006
alf: foxp3 il-2

Defective Activation of Protein Kinase C and Ras-ERK Pathways Limits IL-2 Production and Proliferation by CD4+CD25+ Regulatory T Cells. 2006
alf: il-2 treg

Indexation as a Novel Mechanism of Lymphocyte Homeostasis: The Number of CD4+CD25+ Regulatory T Cells Is Indexed to the Number of IL-2-Producing Cells. 2006
alf: il-2 treg

Interleukin-2 signals during priming are required for secondary expansion of CD8(+) memory T cells. 2006
alf: cd8 il-2 memory

IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT dependent mechanism and induces the expansion of these cells in vivo. 2006
demo: foxp3 il-2

Autoimmune toxicities associated with the administration of antitumor vaccines and low-dose interleukin-2.
alf: il-2 treatment

The dichotomous role of IL-2: tolerance versus immunity. 2006
alf: il-2

Lymphopenia and interleukin-2 therapy alter homeostasis of CD4(+)CD25(+) regulatory T cells. 2005
alf: il-2 lymphopenia treg

Development and function of agonist-induced CD25(+)Foxp3(+) regulatory T cells in the absence of interleukin 2 signaling. 2005
alf: il-2 treg

A function for interleukin 2 in Foxp3-expressing regulatory T cells. 2005
alf: il-2 treg

older →